HDAC9 and Friedreich ataxia: The recent understanding that FRDA disease pathogenesis involves GAA expansion-induced histone deacetylation of the FXN gene has now led to the proposed use of HDAC inhibitors for FRDA therapy (Gottesfeld and Pandolfo, 2009).